Missing Selectivity of Targeted 4β-Phorbol Prodrugs Expected to be Potential Chemotherapeutics-Reference-Cited by-同舟云学术

Missing Selectivity of Targeted 4β-Phorbol Prodrugs Expected to be Potential Chemotherapeutics

Published:2019-12-23 Issue:5 Volume:11 Page:671-677
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Tarvainen Ilari¹,Zimmermann Tomáš²³,Heinonen Pia¹,Jäntti Maria Helena¹,Yli-Kauhaluoma Jari⁴^ORCID,Talman Virpi¹⁵^ORCID,Franzyk Henrik²^ORCID,Tuominen Raimo K.¹,Christensen Søren Brøgger²^ORCID

Affiliation:

1. Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, 00100 Helsinki, Finland

2. Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Jagtvej 162, DK-2100 Copenhagen, Denmark

3. Department of Chemistry of Natural Compounds, Faculty of Food and Biochemical Technology, University of Chemistry and Technology, 166 28 Prague, Czech Republic

4. Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, 00100 Helsinki, Finland

5. National Heart and Lung Institute, Imperial College London, London SW7 2AZ, United Kingdom

Funder

K?benhavns Universitet

Jane ja Aatos Erkon S??ti?

Helsingin Yliopisto

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.9b00554